Qiagen Plans Non-US Offering of Convertible Notes to Raise up to $300M | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen today announced plans to issue convertible notes in a private placement to raise up to $300 million in net proceeds.

The company also plans to buy back convertible notes due in 2026.

Qiagen said that it plans to repurchase up to the full $300 million of its outstanding 2026 convertible notes from non-US holders. It will use cash for the purchase, which will be priced based partly on today's variations in Qiagen's stock price.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.